首页> 外文期刊>Cardiology Journal >Resuscitation of the patient with suspected/confirmed COVID-19 when wearing personal protective equipment: A randomized multicenter crossover simulation trial
【24h】

Resuscitation of the patient with suspected/confirmed COVID-19 when wearing personal protective equipment: A randomized multicenter crossover simulation trial

机译:佩戴个人防护装备时,可疑/确认的Covid-19重新刺激患者:随机多中心交叉模拟试验

获取原文
           

摘要

Background: The aim of the study was to evaluate various methods of chest compressions in patients with suspected/confirmed SARS-CoV-2 infection conducted by medical students wearing full personal protective equipment (PPE) for aerosol generating procedures (AGP). Methods: This was prospective, randomized, multicenter, single-blinded, crossover simulation trial. Thirty-five medical students after an advanced cardiovascular life support course, which included performing 2-min continuous chest compression scenarios using three methods: (A) manual chest compression (CC), (B) compression with CPRMeter, (C) compression with LifeLine ARM device. During resuscitation they are wearing full personal protective equipment for aerosol generating procedures. Results: The median chest compression depth using manual CC, CPRMeter and LifeLine ARM varied and amounted to 40 (38–45) vs. 45 (40–50) vs. 51 (50–52) mm, respectively (p = 0.002). The median chest compression rate was 109 (IQR; 102–131) compressions per minute (CPM) for manual CC, 107 (105–127) CPM for CPRMeter, and 102 (101–102) CPM for LifeLine ARM (p = 0.027). The percentage of correct chest recoil was the highest for LifeLine ARM — 100% (95–100), 80% (60–90) in CPRMeter group, and the lowest for manual CC — 29% (26–48). Conclusions: According to the results of this simulation trial, automated chest compression devices (ACCD) should be used for chest compression of patients with suspected/confirmed COVID-19. In the absence of ACCD, it seems reasonable to change the cardiopulmonary resuscitation algorithm (in the context of patients with suspected/confirmed COVID-19) by reducing the duration of the cardiopulmonary resuscitation cycle from the current 2-min to 1-min cycles due to a statistically significant reduction in the quality of chest compressions among rescuers wearing PPE AGP.
机译:背景:该研究的目的是评估由穿着全部个人防护设备(PPE)的医疗学生为气溶胶产生程序(AGP)进行的疑似/证实SARS-COV-2感染患者的各种胸部压缩方法。方法:这是前瞻性,随机化,多中心,单盲,交叉模拟试验。三十五名医学生在先进的心血管生命支持课程后,其中包括使用三种方法进行2分钟的连续胸部压缩情景:(a)手动胸部压缩(cc),(b)用cprmeter压缩,(c)用生命线压缩臂装置。在复苏期间,他们为气溶胶产生了完整的个人防护设备。结果:使用手动CC,CPRMeter和Lifine臂的中位胸部压缩深度变化,并且分别为40(38-45)与45(40-50)与51(50-52)mm(p = 0.002)。中位数胸部压缩率为109(IQR; 102-131)每分钟按压(CPM),用于CPRMeter的手动CC,107(105-127)CPM,102(101-102)CPM用于生命线臂(P = 0.027) 。正确胸部反冲的百分比是生命线臂 - 100%(95-100),80%(60-90)的CPRMeter组的百分比,并且手动CC - 29%(26-48)中最低。结论:根据该模拟试验的结果,自动胸部压缩装置(ACCD)应用于疑似/确认Covid-19患者的胸部压缩。在没有ACCD的情况下,通过将Carcopulmonymonsconcatication循环的持续时间从当前2分钟降低到期,似乎是改变心肺复苏算法(在患有疑似/确认的Covid-19的患者的上下文中,似乎合理在佩戴PPE AGP的救援人员中胸部按压质量的统计显着降低。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号